• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属有机框架作为氟比洛芬的药物递送系统。

Metal organic frameworks as a drug delivery system for flurbiprofen.

作者信息

Al Haydar Muder, Abid Hussein Rasool, Sunderland Bruce, Wang Shaobin

机构信息

Pharmaceutics Department, College of the Pharmacy, University of Kerbala, Kerbala, Iraq.

Pharmaceutics Department, School of Pharmacy, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.

出版信息

Drug Des Devel Ther. 2017 Sep 11;11:2685-2695. doi: 10.2147/DDDT.S145716. eCollection 2017.

DOI:10.2147/DDDT.S145716
PMID:28979098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5602417/
Abstract

BACKGROUND

Metal organic frameworks (MOFs) have attracted more attention in the last decade because of a suitable pore size, large surface area, and high pore volume. Developing biocompatible MOFs such as the MIL family as a drug delivery system is possible.

PURPOSE

Flurbiprofen (FBP), a nonsteroidal anti-inflammatory agent, is practically insoluble in aqueous solution, and, therefore, needs suitable drug delivery systems. Different biocompatible MOFs such as Ca-MOF and Fe-MILs (53, 100, and 101) were synthesized and employed for FBP delivery.

PATIENTS AND METHODS

A sample of 50 mg of each MOF was mixed and stirred for 24 h with 10 mL of 5 mg FBP in acetonitrile (40%) in a sealed container. The supernatant of the mixture after centrifuging was analyzed by high-performance liquid chromatography to determine the loaded quantity of FBP on the MOF. The overnight-dried solid material after centrifuging the mixture was analyzed for loading percent using X-ray diffraction, Fourier-transform infrared spectroscopy, scanning electron microscopy, nuclear magnetic resonance, and FBP release profile.

RESULTS

The loading values of FBP were achieved at 10.0%±1%, 20%±0.8%, 37%±2.3%, and 46%±3.1% on Ca-MOF, Fe-MIL-53, Fe-MIL-101, and Fe-MIL-100, respectively. The FBP release profiles were investigated in a phosphate buffer solution at pH 7.4. The total release of the FBP after 2 days was obtained at 72.9, 75.2, 78.3, and 90.3% for Ca-MOF, Fe-MIL-100, Fe-MIL-53, and Fe-MIL-101, respectively.

CONCLUSION

The MOFs are shown to be a promising drug delivery option for FBP with a significant loading percent and relatively prolonged drug release.

摘要

背景

在过去十年中,金属有机框架材料(MOFs)因其合适的孔径、大表面积和高孔隙率而备受关注。开发如MIL家族这类具有生物相容性的MOFs作为药物递送系统是可行的。

目的

氟比洛芬(FBP)是一种非甾体抗炎药,在水溶液中几乎不溶,因此需要合适的药物递送系统。合成了不同的生物相容性MOFs,如钙基金属有机框架(Ca-MOF)和铁基金属有机框架(Fe-MILs,包括MIL-53、MIL-100和MIL-101),并将其用于FBP的递送。

患者和方法

将50mg每种MOF样品与10mL含5mg FBP的乙腈(40%)在密封容器中混合并搅拌24小时。混合物离心后的上清液通过高效液相色谱法进行分析,以确定FBP在MOF上的负载量。对混合物离心后过夜干燥的固体材料,使用X射线衍射、傅里叶变换红外光谱、扫描电子显微镜、核磁共振和FBP释放曲线分析其负载百分比。

结果

FBP在Ca-MOF、Fe-MIL-53、Fe-MIL-101和Fe-MIL-100上的负载值分别达到10.0%±1%、20%±0.8%、37%±2.3%和46%±3.1%。在pH 7.4的磷酸盐缓冲溶液中研究了FBP的释放曲线。2天后,Ca-MOF、Fe-MIL-100、Fe-MIL-53和Fe-MIL-101的FBP总释放率分别为72.9%、75.2%、78.3%和90.3%。

结论

MOFs被证明是一种有前景的FBP药物递送选择,具有显著的负载百分比和相对较长的药物释放时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/f21ba969be95/dddt-11-2685Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/781462cec021/dddt-11-2685Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/d9f2876616f6/dddt-11-2685Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/e3bf8c1f73ce/dddt-11-2685Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/de397df9970d/dddt-11-2685Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/f21ba969be95/dddt-11-2685Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/781462cec021/dddt-11-2685Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/d9f2876616f6/dddt-11-2685Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/e3bf8c1f73ce/dddt-11-2685Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/de397df9970d/dddt-11-2685Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada4/5602417/f21ba969be95/dddt-11-2685Fig5.jpg

相似文献

1
Metal organic frameworks as a drug delivery system for flurbiprofen.金属有机框架作为氟比洛芬的药物递送系统。
Drug Des Devel Ther. 2017 Sep 11;11:2685-2695. doi: 10.2147/DDDT.S145716. eCollection 2017.
2
Multimetal organic frameworks as drug carriers: aceclofenac as a drug candidate.多金属有机框架作为药物载体:双氯芬酸作为候选药物。
Drug Des Devel Ther. 2018 Dec 18;13:23-35. doi: 10.2147/DDDT.S182983. eCollection 2019.
3
Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.生物相容的基于铁的微孔金属有机骨架作为缓释抗癌药物载体。
Molecules. 2018 Sep 28;23(10):2490. doi: 10.3390/molecules23102490.
4
Highly efficient Fenton and enzyme-mimetic activities of NH-MIL-88B(Fe) metal organic framework for methylene blue degradation.NH-MIL-88B(Fe) 金属有机骨架对亚甲基蓝降解具有高效的芬顿和酶模拟活性。
Sci Rep. 2018 Mar 26;8(1):5159. doi: 10.1038/s41598-018-23557-2.
5
Development of Biocompatible Iron-Carboxylate Metal Organic Frameworks for pH-Responsive Drug Delivery Application.用于 pH 响应型药物递送应用的生物相容型铁羧酸基金属有机框架的开发。
J Nanosci Nanotechnol. 2019 Feb 1;19(2):646-654. doi: 10.1166/jnn.2019.15402.
6
Metal-organic frameworks, NH-MIL-88(Fe), as carriers for ophthalmic delivery of brimonidine.金属有机骨架材料 NH-MIL-88(Fe) 作为溴莫尼定眼部给药载体。
Acta Biomater. 2018 Oct 1;79:344-353. doi: 10.1016/j.actbio.2018.08.023. Epub 2018 Aug 19.
7
Preparation of GO/MIL-101(Fe,Cu) composite and its adsorption mechanisms for phosphate in aqueous solution.GO/MIL-101(Fe,Cu) 复合材料的制备及其对水溶液中磷酸盐的吸附机制。
Environ Sci Pollut Res Int. 2021 Oct;28(37):51391-51403. doi: 10.1007/s11356-021-14206-9. Epub 2021 May 13.
8
A pH-Responsive Drug-Delivery System Based on Apatinib-Loaded Metal-Organic Frameworks for Ferroptosis-Targeted Synergistic Anti-Tumor Therapy.基于载阿帕替尼金属有机框架的 pH 响应型药物递释系统用于铁死亡靶向协同抗肿瘤治疗。
Int J Nanomedicine. 2024 Sep 4;19:9055-9070. doi: 10.2147/IJN.S477248. eCollection 2024.
9
Effect of pore size of FSM-16 on the entrapment of flurbiprofen in mesoporous structures.FSM-16孔径对氟比洛芬在介孔结构中包封的影响。
Chem Pharm Bull (Tokyo). 2005 Aug;53(8):974-7. doi: 10.1248/cpb.53.974.
10
Metal organic frameworks MIL-100(Fe) as an efficient adsorptive material for phosphate management.金属有机骨架 MIL-100(Fe) 作为一种用于磷酸盐管理的有效吸附材料。
Environ Res. 2019 Feb;169:229-236. doi: 10.1016/j.envres.2018.11.013. Epub 2018 Nov 14.

引用本文的文献

1
Quality by Design (QbD)-Based Development of a Self-Nanoemulsifying Drug Delivery System for the Ocular Delivery of Flurbiprofen.基于质量源于设计(QbD)理念开发用于氟比洛芬眼部给药的自纳米乳化药物递送系统
Pharmaceutics. 2025 May 9;17(5):629. doi: 10.3390/pharmaceutics17050629.
2
Magnetic Nanoparticles Combined With Pulsed Electromagnetic Field Alleviate Chondrocyte Necroptosis in Osteoarthritis.磁性纳米颗粒联合脉冲电磁场减轻骨关节炎中的软骨细胞坏死性凋亡
FASEB J. 2025 May 31;39(10):e70652. doi: 10.1096/fj.202401959RR.
3
Formation and evaluation of doxorubicin and cromoglycate metal-organic framework for anti-cancer activity.

本文引用的文献

1
Screening of bio-compatible metal-organic frameworks as potential drug carriers using Monte Carlo simulations.使用蒙特卡罗模拟筛选生物相容性金属有机框架作为潜在药物载体
J Mater Chem B. 2014 Feb 21;2(7):766-774. doi: 10.1039/c3tb21328e. Epub 2013 Dec 23.
2
Structuralization of Ca(2+)-Based Metal-Organic Frameworks Prepared via Coordination Replication of Calcium Carbonate.通过碳酸钙的配位复制制备的钙基金属有机框架的结构化
Inorg Chem. 2016 Apr 4;55(7):3700-5. doi: 10.1021/acs.inorgchem.6b00397. Epub 2016 Mar 22.
3
Brønsted acidity in metal-organic frameworks.
用于抗癌活性的阿霉素和色甘酸金属有机框架的形成与评价
Nanomedicine (Lond). 2025 Mar;20(5):467-479. doi: 10.1080/17435889.2025.2459059. Epub 2025 Jan 31.
4
Microwave-Responsive Metal-Organic Frameworks (MOFs) for Enhanced In Vitro Controlled Release of Doxorubicin.用于增强阿霉素体外控释的微波响应性金属有机框架材料(MOFs)
Nanomaterials (Basel). 2024 Jun 24;14(13):1081. doi: 10.3390/nano14131081.
5
Physiochemical characterization of metal organic framework materials: A mini review.金属有机骨架材料的物理化学表征:一篇综述短文
Heliyon. 2023 Dec 16;10(1):e23840. doi: 10.1016/j.heliyon.2023.e23840. eCollection 2024 Jan 15.
6
Current status and prospects of MIL-based MOF materials for biomedicine applications.用于生物医学应用的基于金属-有机骨架(MIL)的MOF材料的现状与前景
RSC Med Chem. 2023 Sep 1;14(10):1914-1933. doi: 10.1039/d3md00397c. eCollection 2023 Oct 18.
7
Design and degradation of permanently porous vitamin C and zinc-based metal-organic framework.永久性多孔维生素C和锌基金属有机框架的设计与降解
Commun Chem. 2022 Feb 25;5(1):24. doi: 10.1038/s42004-022-00639-x.
8
Perspectives of metal-organic framework nanosystem to overcome tumor drug resistance.金属有机框架纳米系统克服肿瘤耐药性的研究进展
Cancer Drug Resist. 2022 Oct 18;5(4):954-970. doi: 10.20517/cdr.2022.76. eCollection 2022.
9
Recent Advances in Metal-Organic-Framework-Based Nanocarriers for Controllable Drug Delivery and Release.基于金属有机框架的纳米载体用于可控药物递送与释放的研究进展
Pharmaceutics. 2022 Dec 13;14(12):2790. doi: 10.3390/pharmaceutics14122790.
10
Fabrication of Functional bioMOF-100 Prototype as Drug Delivery System for Breast Cancer Therapy.制备用于乳腺癌治疗的功能性生物金属有机框架-100原型作为药物递送系统。
Pharmaceutics. 2022 Nov 15;14(11):2458. doi: 10.3390/pharmaceutics14112458.
金属有机框架中的布朗斯特酸度。
Chem Rev. 2015 Jul 22;115(14):6966-97. doi: 10.1021/acs.chemrev.5b00221. Epub 2015 Jun 19.
4
Porous nanosized particles: preparation, properties, and applications.多孔纳米颗粒:制备、性质及应用。
Chem Rev. 2013 Aug 14;113(8):6734-60. doi: 10.1021/cr300439k. Epub 2013 May 24.
5
Flurbiprofen-loaded stealth liposomes: studies on the development, characterization, pharmacokinetics, and biodistribution.载有氟比洛芬的隐形脂质体:关于其开发、表征、药代动力学和生物分布的研究
J Young Pharm. 2012 Oct;4(4):209-19. doi: 10.4103/0975-1483.104364.
6
Metal-organic frameworks as potential drug delivery systems.金属有机骨架作为潜在的药物传递系统。
Expert Opin Drug Deliv. 2013 Jan;10(1):89-101. doi: 10.1517/17425247.2013.741583. Epub 2012 Nov 10.
7
Cyclohexane selective oxidation over metal-organic frameworks of MIL-101 family: superior catalytic activity and selectivity.MIL-101 家族金属有机骨架上的环己烷选择性氧化:优异的催化活性和选择性。
Chem Commun (Camb). 2012 Jul 11;48(54):6812-4. doi: 10.1039/c2cc31877f. Epub 2012 Jun 1.
8
Metal-organic frameworks in biomedicine.生物医学中的金属有机框架
Chem Rev. 2012 Feb 8;112(2):1232-68. doi: 10.1021/cr200256v. Epub 2011 Dec 14.
9
Porous metal organic framework nanoparticles to address the challenges related to busulfan encapsulation.多孔金属有机骨架纳米粒子解决与包裹白消安相关的挑战。
Nanomedicine (Lond). 2011 Dec;6(10):1683-95. doi: 10.2217/nnm.11.69.
10
Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles.pH 敏感型聚乙二醇-聚组氨酸-聚乳酸纳米粒的抗肿瘤药物递送。
J Control Release. 2011 May 30;152(1):49-56. doi: 10.1016/j.jconrel.2011.02.031. Epub 2011 Mar 22.